- Home
- AEON vs KXIN Comparison
AEON vs KXIN Comparison
Compare AEON & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEON
- KXIN
- Stock Information
- Founded
- AEON N/A
- KXIN 2015
- Country
- AEON United States
- KXIN China
- Employees
- AEON N/A
- KXIN N/A
- Industry
- AEON Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- AEON Health Care
- KXIN Consumer Discretionary
- Exchange
- AEON Nasdaq
- KXIN Nasdaq
- Market Cap
- AEON 8.0M
- KXIN 9.4M
- IPO Year
- AEON N/A
- KXIN N/A
- Fundamental
- Price
- AEON $0.64
- KXIN $0.89
- Analyst Decision
- AEON Strong Buy
- KXIN
- Analyst Count
- AEON 1
- KXIN 0
- Target Price
- AEON $360.00
- KXIN N/A
- AVG Volume (30 Days)
- AEON 104.9K
- KXIN 163.0K
- Earning Date
- AEON 08-19-2025
- KXIN 01-01-0001
- Dividend Yield
- AEON N/A
- KXIN N/A
- EPS Growth
- AEON N/A
- KXIN N/A
- EPS
- AEON 117.22
- KXIN N/A
- Revenue
- AEON N/A
- KXIN N/A
- Revenue This Year
- AEON N/A
- KXIN N/A
- Revenue Next Year
- AEON N/A
- KXIN N/A
- P/E Ratio
- AEON $0.01
- KXIN N/A
- Revenue Growth
- AEON N/A
- KXIN N/A
- 52 Week Low
- AEON $0.38
- KXIN $0.64
- 52 Week High
- AEON $115.57
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- AEON 32.28
- KXIN 59.53
- Support Level
- AEON $0.70
- KXIN $0.77
- Resistance Level
- AEON $0.75
- KXIN $1.03
- Average True Range (ATR)
- AEON 0.05
- KXIN 0.07
- MACD
- AEON -0.01
- KXIN 0.02
- Stochastic Oscillator
- AEON 1.33
- KXIN 80.24
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.